Primary Myelofibrosis Withdrawn Phase 1 Trials for Melphalan (DB01042)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02528877Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisSupportive Care